Clinical Trials Arena on MSN2d
PDS Biotechnology commences trial for head and neck squamous cell carcinomaPDS Biotechnology has commenced the randomised, multi-centre Phase III clinical trial, VERSATILE-003, to assess the efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback